Compare KFFB & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KFFB | SRTS |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7M | 44.3M |
| IPO Year | 2004 | 2016 |
| Metric | KFFB | SRTS |
|---|---|---|
| Price | $4.79 | $2.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 1.3K | ★ 60.1K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 109.52 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | $15,000.00 | ★ $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | $31.93 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.51 | $2.66 |
| 52 Week High | $4.98 | $5.92 |
| Indicator | KFFB | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 55.10 | 30.66 |
| Support Level | $4.26 | N/A |
| Resistance Level | $4.86 | $3.28 |
| Average True Range (ATR) | 0.11 | 0.17 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 83.87 | 8.30 |
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.